Reported about 11 hours ago
Switzerland's economic resilience in the face of a strong franc is increasingly supported by the pharmaceutical sector, which now represents a significant portion of the country's GDP. With major players like Roche and Novartis leading the way, Swiss drug exports are more insulated against currency fluctuations compared to other industries. This trend allows the Swiss National Bank to navigate monetary policy challenges with greater flexibility, although reliance on the pharmaceutical sector brings its own risks, especially due to external factors such as regulations in the US market.
Source: YAHOO